|
Message on the Report of the High-Level Panel on Access to Medicines, “Promoting Innovation and Access to Health Technologies” 关于获得药品问题高级别小组报告“促进创新和获得保健技术”的致辞 22 November 2016 2016年11月22日 Despite great scientific progress, all countries, from the poorest to the most prosperous, are facing challenges related to the costs of many medicines, diagnostics, medical devices and vaccines.Since rising costs of health technologies can push people into poverty, we have a shared duty to find solutions to ensure access to these technologies for all. 尽管取得了巨大的科学进步，但所有国家，无论是最贫穷还是最繁荣的国家，都面临着许多药品、诊断、医疗器械和疫苗费用高昂带来的挑战。由于保健技术的成本上涨可能使人们陷入贫穷，我们有共同的责任找到解决办法，以确保所有人都能获得这些技术。 Soon after Member States adopted the 2030 Agenda for Sustainable Development, I convened an independent High-Level Panel on Access to Medicines to “recommend solutions for remedying the policy incoherence between the justifiable rights of inventors, international human rights law, trade rules and public health in the context of health technologies”. 在会员国通过《2030年可持续发展议程》后不久，我召集了一个独立的获得药品问题高级别小组，负责“就如何纠正在保健技术方面发明者的合理权利、国际人权法、贸易规则和公共健康之间的政策不一致问题提出建议”。 | 
